botensilimab,balstilimab
agenus
$agen agenus shows unprecedented activity for botensilimab/balstilimab combination in microsatellite stable colorectal cancer at esmo world gi congress 
Data services for biopharma/financial industries. #Pharma & #biotech competitive intelligence; clinical trials tools: https://t.co/A77u9Q84Dc  https://t.co/lvTtwarrGT